BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 25462194)

  • 21. Orexins and orexin receptors: from molecules to integrative physiology.
    Matsuki T; Sakurai T
    Results Probl Cell Differ; 2008; 46():27-55. PubMed ID: 18204827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders.
    Kilduff TS; Peyron C
    Trends Neurosci; 2000 Aug; 23(8):359-65. PubMed ID: 10906799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The physiological role of orexins.
    Martynska L; Wolinska-Witort E; Chmielowska M; Bik W; Baranowska B
    Neuro Endocrinol Lett; 2005 Aug; 26(4):289-92. PubMed ID: 16135995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
    Terao A; Haruyama T; Kimura K
    Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical function of orexin/hypocretin circuits in a mouse model of Huntington's disease.
    Williams RH; Morton AJ; Burdakov D
    Neurobiol Dis; 2011 Jun; 42(3):438-45. PubMed ID: 21324360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle.
    Salin-Pascual RJ
    Isr Med Assoc J; 2001 Feb; 3(2):144-6. PubMed ID: 11344826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of orexin in the central regulation of glucose and energy homeostasis.
    Tsuneki H; Wada T; Sasaoka T
    Endocr J; 2012; 59(5):365-74. PubMed ID: 22293586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic orexins/hypocretins as regulators of breathing.
    Williams RH; Burdakov D
    Expert Rev Mol Med; 2008 Oct; 10():e28. PubMed ID: 18828950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptides as possible targets in sleep disorders.
    Nishino S; Fujiki N
    Expert Opin Ther Targets; 2007 Jan; 11(1):37-59. PubMed ID: 17150033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
    Tsuneki H; Wada T; Sasaoka T
    Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orexins/hypocretins and aminergic systems.
    Eriksson KS; Sergeeva OA; Haas HL; Selbach O
    Acta Physiol (Oxf); 2010 Mar; 198(3):263-75. PubMed ID: 19566795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To eat or to sleep? Orexin in the regulation of feeding and wakefulness.
    Willie JT; Chemelli RM; Sinton CM; Yanagisawa M
    Annu Rev Neurosci; 2001; 24():429-58. PubMed ID: 11283317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypocretin disturbance and sleep disorders].
    Billiard M
    Bull Acad Natl Med; 2011 Oct; 195(7):1567-78; discussion 1579-81. PubMed ID: 22812161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology.
    Sakurai T
    Regul Pept; 2005 Mar; 126(1-2):3-10. PubMed ID: 15620407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.
    Mignot E; Taheri S; Nishino S
    Nat Neurosci; 2002 Nov; 5 Suppl():1071-5. PubMed ID: 12403989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice.
    Liu M; Thankachan S; Kaur S; Begum S; Blanco-Centurion C; Sakurai T; Yanagisawa M; Neve R; Shiromani PJ
    Eur J Neurosci; 2008 Oct; 28(7):1382-93. PubMed ID: 18973565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homeostatic, circadian, and emotional regulation of sleep.
    Saper CB; Cano G; Scammell TE
    J Comp Neurol; 2005 Dec; 493(1):92-8. PubMed ID: 16254994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypothalamic neuropeptides implicated in the regulation of sleep/wakefulness states].
    Sakurai T
    Brain Nerve; 2012 Jun; 64(6):629-37. PubMed ID: 22647470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.
    Fujiki N; Nishino S
    CNS Neurol Disord Drug Targets; 2007 Feb; 6(1):45-62. PubMed ID: 17305553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent trends in orexin research--2010 to 2015.
    Boss C; Roch C
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2875-87. PubMed ID: 26045032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.